A study of irinotecan, fluorouracil, calcium folinate, zimberelimab, and domvanalimab for patients with metastatic gastro-enteropancreatic neuroendocrine carcinoma.

Registered drugNo placebo

A study of irinotecan, fluorouracil, calcium folinate, zimberelimab, and domvanalimab for patients with metastatic gastro-enteropancreatic neuroendocrine carcinoma.

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Hospices Civils De Lyon

Contact Research Centre

Endocrine ophthalmopathy

Not yet recruiting

A study testing teprotumumab compared to placebo in adult patients with moderate-to-severe active thyroid eye disease

Investigational

A study testing teprotumumab compared to placebo in adult patients with moderate-to-severe active thyroid eye disease

Investigational

France

Participants:18–64 years · 65+ years
Substances:Teprotumumab
Sponsor:Horizon Therapeutics USA Inc.

Contact Research Centre

Endocrine ophthalmopathy+1

Not yet recruiting

A study to test if atorvastatin can prevent eye disease in patients newly diagnosed with Graves' disease

Registered drugNo placebo

A study to test if atorvastatin can prevent eye disease in patients newly diagnosed with Graves' disease

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Atorvastatin
Sponsor:Region Skane

Contact Research Centre

Type 1 diabetes mellitus+1

Not yet recruiting

A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

Registered drugNo placebo

A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

Registered drugNo placebo

Denmark

Participants:18–64 years
Substances:Dapagliflozin
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Diabetes mellitus+2

Not yet recruiting

A Study of Semaglutide for Diabetic Patients with Heart Attack or Unstable Angina to Measure Changes in Coronary Artery Plaque Using Imaging

Registered drugNo placebo

A Study of Semaglutide for Diabetic Patients with Heart Attack or Unstable Angina to Measure Changes in Coronary Artery Plaque Using Imaging

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Azienda Ospedaliero-Universitaria Maggiore Della Carita

Contact Research Centre

Type 2 diabetes mellitus

Not yet recruiting

Study of semaglutide and dapagliflozin effects on heart muscle insulin resistance in patients with type 2 diabetes

Registered drugNo placebo

Study of semaglutide and dapagliflozin effects on heart muscle insulin resistance in patients with type 2 diabetes

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Contact Research Centre

Hypoparathyroidism

Not yet recruiting

A study testing magnesium aspartate to prevent long-term low parathyroid hormone levels in patients after thyroid surgery

Registered drug

A study testing magnesium aspartate to prevent long-term low parathyroid hormone levels in patients after thyroid surgery

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:MAGNESIUM L-ASPARTATE HYDROCHLORIDE TRIHYDRATE
Sponsor:Henry Dunant Hospital Center

Contact Research Centre

Substances studied in this area

The therapies tested most often in Endocrine disorders trials.

Semaglutide46 clinical trials Dapagliflozin21 clinical trials Empagliflozin14 clinical trials Sodium Chloride13 clinical trials Cisplatin12 clinical trials Etoposide12 clinical trials Metformin Hydrochloride12 clinical trials Carboplatin11 clinical trials Insulin Glargine11 clinical trials

Endocrine disorders – page 19

Conditions in this area

Clinical trials in Endocrine disorders

497 clinical trials

Type 1 diabetes mellitus+1

Study of anakinra and a drug combination to prevent blood clots in patients receiving a pancreatic transplant

Hypoparathyroidism

A study to evaluate the safety and effects of palopegteriparatide in adolescents with chronic hypoparathyroidism

Primary bilateral macronodular adrenal hyperplasia

Study of the effect of metyrapone in patients with mild Cushing syndrome caused by primary bilateral macronodular adrenal hyperplasia

Congenital growth hormone deficiency

Study of the effects of Ibutamoren Mesilate in prepubertal children with growth hormone deficiency

Diabetic neuropathy

Study of the effectiveness and safety of alpha-lipoic acid and benfotiamine for the treatment of symptoms in patients with diabetic neuropathy

Neuroendocrine carcinoma metastatic

A study of irinotecan, fluorouracil, calcium folinate, zimberelimab, and domvanalimab for patients with metastatic gastro-enteropancreatic neuroendocrine carcinoma.

Endocrine ophthalmopathy

A study testing teprotumumab compared to placebo in adult patients with moderate-to-severe active thyroid eye disease

Endocrine ophthalmopathy+1

A study to test if atorvastatin can prevent eye disease in patients newly diagnosed with Graves' disease

Type 1 diabetes mellitus+1

A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

Diabetes mellitus+2

A Study of Semaglutide for Diabetic Patients with Heart Attack or Unstable Angina to Measure Changes in Coronary Artery Plaque Using Imaging

Type 2 diabetes mellitus

Study of semaglutide and dapagliflozin effects on heart muscle insulin resistance in patients with type 2 diabetes

Hypoparathyroidism

A study testing magnesium aspartate to prevent long-term low parathyroid hormone levels in patients after thyroid surgery

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.